Forgot your password?
Haven't registered yet?
7/23/2014CMSC INforMS: PLEGRIDY (Peginterferon beta-1a) Approved in the EU for the Treatment of MS
7/3/2014CMSC INforMS: Teva files Citizen Petition with the US FDA regarding the Complexity of COPAXONE
6/30/2014CMSC INforMS: Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
6/16/2014CMSC INforMS: Biogen Idec and AbbVie Announce Results from Phase 3 Study Investigating Daclizumab
5/31/2014CMSC Press Release: Official Reports from the 2014 Cooperative Meeting of CMSC & ACTRIMS - 5/31/2014
9/9/2013 » 9/9/2014Maximizing the Impact of Symptom Intervention in the Management of Patients with Multiple Sclerosis
2/12/2014 » 2/12/2015Individualized Learning Plan: Confronting Current Challenges in Multiple Sclerosis Treatment
10/10/2014 » 10/11/20144th International Symposium on Gait and Balance in Multiple Sclerosis: The Role of Cognition
10/18/2014Cognitive Issues in Multiple Sclerosis Update